Management of nephrotoxicity of chemotherapy and targeted agents: 2020
- PMID: 33414992
- PMCID: PMC7783750
Management of nephrotoxicity of chemotherapy and targeted agents: 2020
Abstract
Nephrotoxic effects of certain chemotherapeutic agents such as cisplatin and ifosfamide has been well documented and these effects are carefully managed by oncologists during their usage. The introduction of targeted agents has added a new challenge to cancer management as their nephrotoxic effects and associated management is in the process of being adopted by oncologists. This work is a compilation of side effects on the renal system due to various chemotherapeutic, immunotherapeutic and targeted agents followed by their recommended management.
Keywords: Nephrotoxicity; acute kidney injury; chronic kidney disease; side effects; tumor lysis syndrome.
AJCR Copyright © 2020.
Conflict of interest statement
None.
References
-
- Perazella MA. Onco-nephrology: renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol. 2012;7:1713–1721. - PubMed
-
- Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician. 2008;78:743–750. - PubMed
-
- Malyszko J, Kozlowska K, Kozlowski L, Malyszko J. Nephrotoxicity of anticancer treatment. Nephrol Dial Transplant. 2017;32:924–936. - PubMed
Publication types
LinkOut - more resources
Full Text Sources